C J Scott - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C J Scott

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

Frontiers in Pharmacology|December 20, 2023

Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategyP Smyth, L Ferguson, J F Burrows, et al.

Cell Death & Disease|October 10, 2014

Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicityD Schmid, G E Jarvis, F Fay, et al.

British Journal of Cancer|October 13, 2011

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyJ A Gormley, S M Hegarty, A O'Grady, et al.

Pageof 7

Search research articles

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

Frontiers in Pharmacology|December 20, 2023

Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategyP Smyth, L Ferguson, J F Burrows, et al.

Cell Death & Disease|October 10, 2014

Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicityD Schmid, G E Jarvis, F Fay, et al.

British Journal of Cancer|October 13, 2011

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyJ A Gormley, S M Hegarty, A O'Grady, et al.

Pageof 7